Healthcare Realty Trust Incorporated (NYSE:HR) today announced results for the third quarter ended September 30, 2022. The Company reported net income attributable to common stockholders of $28.3 million, or $0.08 per diluted common share, for the quarter ended September 30, 2022. Normalized FFO for the three months ended September 30, 2022 totaled $129.4 million, or $0.39 per diluted common share.

Salient quarterly highlights include:

  • The Company completed the merger with Healthcare Trust of America, Inc. on July 20, 2022. Legacy HR was the accounting acquirer in the reverse merger structure. Unless otherwise noted, all financial information prior to the completion of the merger relates to Legacy HR.
  • Normalized FFO per share totaled $0.39. With the full quarter pro-forma and run-rate adjustments as outlined below, expected run-rate normalized FFO is $0.40 per share. These quarterly amounts include the negative effect of non-cash, merger-related fair value debt adjustments of $0.03 per share. See the section below for a reconciliation of these items.
  • Same store cash NOI for the third quarter increased 2.8% over the prior year. For the trailing twelve months ended September 30, 2022, same store cash NOI grew 2.4%. The same store portfolio includes 589 properties from combined Legacy HR and HTA, comprising 83% of total cash NOI.
  • Predictive growth measures in the same store portfolio include:
    • Average in-place rent increases of 2.64%
    • Future annual contractual increases of 2.8% for leases commencing in the quarter
    • Weighted average cash leasing spreads of 2.9% on 634,000 square feet renewed:
      • 10% (<0% spread)
      • 26% (0-3%)
      • 43% (3-4%)
      • 22% (>4%)
    • Tenant retention of 79.1%
  • Portfolio leasing activity in the third quarter totaled 1,086,000 square feet related to 317 leases:
    • 694,000 square feet of renewals
    • 392,000 square feet of new and expansion leases
  • In the third quarter, the Company realized $16.4 million of annualized synergies, or nearly half of the projected $33-$36 million of annual G&A synergies. The Company expects to realize approximately $18 million of remaining annual G&A savings evenly over the next three quarters. This equates to an incremental $1.5 million of G&A savings for each of the next three quarters.
  • Associated with the merger, the Company has closed $922 million in joint ventures and asset sale transactions at a weighted average cap rate of 4.6%. Transactions totaling $105 million are under contract and expected to close in November. In December, the Company expects to complete the remaining sales that will bring the total to over $1.1 billion at an expected weighted average cap rate of 4.8%.
  • Since the end of the second quarter, the Company acquired nine medical office buildings totaling 249,000 square feet for $94.9 million. The properties are all located in existing markets and expand clusters in high growth markets, including Atlanta, Nashville and Raleigh.
  • Since the end of the third quarter, the Company entered into new interest rate swaps totaling $250 million, bringing fixed rate debt to 86% of total debt, excluding the remaining balance on the asset sale term loan.
  • Run-rate net debt to adjusted EBITDA on a full quarter proforma basis was 6.3 times at the end of the quarter. For a reconciliation to expected run-rate amounts, see the section below.
  • A dividend of $0.31 per share will be paid on November 30, 2022 to stockholders of record on November 15, 2022.

The following table provides a reconciliation of the current quarter full proforma normalized FFO, FAD and Adjusted EBITDA to an expected quarterly run-rate. The expected run-rates do not adjust for future changes in interest rates, portfolio NOI growth, or external investment activity. The expected run-rates also do not include any dispositions beyond those expected to repay the $1.125 billion asset sale term loan.

RUN-RATE ADJUSTED EBITDA, NORMALIZED FFO AND FAD        
  NORMALIZED FFO   FAD   ADJUSTED EBITDA   NET DEBT  
Q3 2022 proforma full quarter $150,884   $118,835   $212,759   $5,840,802  
NOI adjustments for asset sales:1        
Q3 NOI recognized on assets sold during the quarter 2   (3,997)     (3,944)          
October asset sales completed   (1,625)     (1,600)     (1,625)     (136,000)  
Expected November asset sales   (1,400)     (1,300)     (1,400)     (105,000)  
Expected December asset sales   (3,000)     (2,875)     (3,000)     (182,000)  
Q3 acquisition timing 2   918     865          
Q3 recognized interest expense on the asset sale term loan   5,419     5,151          
Reversal of Q3 seasonal utilities   2,500     2,500     2,500      
Remaining expected G&A synergies 3   4,500     4,500     4,500      
Normalized maintenance capex 4       4,500          
Adjusted run-rate $154,199   $126,632   $213,734   $5,417,802  
Per share $0.40   $0.33    
Net debt to adjusted EBITDA       6.3x  
FFO wtd avg common shares outstanding - diluted   384,615     384,615      
Merger-related fair value debt adjustment $11,844        
Per share $0.03        
  1. FFO and EBITDA includes the impact of straight-line rent.
  2. Adjustments to reflect quarterly NOI/EBITDA from properties acquired or disposed of in the quarter.
  3. The Company expects to realize $1.5 million per quarter in incremental G&A savings over each of the next three quarters.
  4. Quarterly maintenance capex as a percentage of NOI was 17.6%. The Company expects a run rate of 16% of run-rate adjusted cash NOI.

Healthcare Realty Trust is a real estate investment trust that integrates owning, managing, financing and developing income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of September 30, 2022, the Company was invested in over 700 real estate properties totaling more than 40 million square feet and provided leasing and property management services to over 35 million square feet nationwide.

 

Additional information regarding the Company, including this quarter's operations, can be found at www.healthcarerealty.com. Please contact the Company at 615.269.8175 to request a printed copy of this information. In addition to the historical information contained within, this press release contains certain forward-looking statements with respect to the Company. Forward-looking statements are statements that are not descriptions of historical facts and include statements regarding management’s intentions, beliefs, expectations, plans or predictions of the future, within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Because such statements include risks, uncertainties and contingencies, actual results may differ materially and in adverse ways from those expressed or implied by such forward-looking statements. These risks, uncertainties and contingencies include, without limitation, the following: failure to realize the expected benefits of the Merger; significant transaction costs and/or unknown or inestimable liabilities; the risk that HTA’s business will not be integrated successfully or that such integration may be more difficult, time-consuming or costly than expected; risks related to future opportunities and plans for the Company, including the uncertainty of expected future financial performance and results of the Company; the possibility that, if the Company does not achieve the perceived benefits of the Merger as rapidly or to the extent anticipated by financial analysts or investors, the market price of the Company’s common stock could decline; general adverse economic and local real estate conditions; changes in economic conditions generally and the real estate market specifically; legislative and regulatory changes, including changes to laws governing the taxation of REITs and changes to laws governing the healthcare industry; the availability of capital; changes in interest rates; competition in the real estate industry; the supply and demand for operating properties in the Company’s proposed market areas; changes in accounting principles generally accepted in the US; policies and guidelines applicable to REITs; the availability of properties to acquire; the availability of financing; pandemics and other health concerns, and the measures intended to prevent their spread, including the currently ongoing COVID-19 pandemic; and the potential material adverse effect these matters may have on the Company’s business, results of operations, cash flows and financial condition. Additional information concerning the Company and its business, including additional factors that could materially and adversely affect the Company’s financial results, include, without limitation, the risks described under Part I, Item 1A - Risk Factors, in the Company’s 2021 Annual Report on Form 10-K and in its other filings with the SEC.

Consolidated Balance Sheets 1
DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA
ASSETS        
    2Q 2022
  3Q 2022   Combined   Legacy HR   Legacy HTA  
Real estate properties        
Land $1,449,550   $1,104,700   $456,306   $648,394  
Buildings and improvements   11,439,797     11,447,844     4,673,026     6,774,818  
Lease intangibles   968,914     382,738         382,738  
Personal property   11,680     11,799     11,799      
Investment in financing receivables, net   118,919     118,446     118,446      
Financing lease right-of-use assets   79,950     71,632     71,632      
Construction in progress   43,148     31,980     16,728     15,252  
Land held for development   73,321     22,952     22,952      
Total real estate investments   14,185,279     13,192,091     5,370,889     7,821,202  
Less accumulated depreciation and amortization   (1,468,736 )   (3,102,055 )   (1,402,509 )   (1,699,546 )
Total real estate investments, net   12,716,543     10,090,036     3,968,380     6,121,656  
Cash and cash equivalents   57,583     64,026     34,312     29,714  
Restricted cash       4,559         4,559  
Assets held for sale, net   185,074              
Operating lease right-of-use assets   321,365     353,807     126,204     227,603  
Investments in unconsolidated joint ventures   327,752     272,851     210,781     62,070  
Other assets, net and goodwill   587,126     578,948     209,200     369,748  
Total assets $14,195,443   $11,364,227   $4,548,877   $6,815,350  
         
LIABILITIES AND STOCKHOLDERS' EQUITY        
    2Q 2022
  3Q 2022   Combined   Legacy HR   Legacy HTA  
Liabilities        
Notes and bonds payable $5,570,139   $5,158,398   $2,063,755   $3,094,643  
Accounts payable and accrued liabilities   231,018     255,883     84,210     171,673  
Liabilities of properties held for sale   10,644              
Operating lease liabilities   268,840     291,739     94,748     196,991  
Financing lease liabilities   72,378     62,195     62,195      
Other liabilities   203,398     176,844     66,102     110,742  
Total liabilities   6,356,417     5,945,059     2,371,010     3,574,049  
Stockholders' equity        
Preferred stock, $0.01 par value; 200,000 shares authorized                
Common stock, $0.01 par value; 1,000,000 shares authorized   3,806     3,807     1,516     2,291  
Additional paid-in capital   9,586,556     9,185,292     4,002,526     5,182,766  
Accumulated other comprehensive income/(loss)   5,524     4,536     (1,250 )   5,786  
Cumulative net income attributable to common stockholders   1,342,819     1,314,515     1,314,515      
Cumulative dividends 1   (3,211,492 )   (5,171,621 )   (3,139,440 )   (2,032,181 )
Total stockholders' equity   7,727,213     5,336,529     2,177,867     3,158,662  
Noncontrolling interest   111,813     82,639         82,639  
Total Equity   7,839,026     5,419,168     2,177,867     3,241,301  
Total liabilities and stockholders' equity $14,195,443   $11,364,227   $4,548,877   $6,815,350  
  1. Includes legacy HTA's cumulative dividends in excess of earnings.
Consolidated Statements of Income 1
DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA
           
  3Q 2022 2Q 2022
  AS REPORTED   PROFORMA FULLQUARTER   COMBINED   LEGACY HR   LEGACY HTA  
Revenues          
Rental income   298,931     344,251     338,916     140,632     198,284  
Interest income   3,366     3,750     1,957     1,957      
Other operating   4,057     4,057     4,587     2,738     1,849  
    306,354     352,058     345,460     145,327     200,133  
Expenses          
Property operating   112,473     127,172     120,383     57,010     63,373  
General and administrative   16,741     18,956     24,783     10,540     14,243  
Acquisition and pursuit costs 2   482     482     1,449     1,352     97  
Merger-related costs   79,402     79,402     12,192     7,085     5,107  
Depreciation and amortization   158,117     186,643     130,782     55,731     75,051  
    367,215     412,655     289,589     131,718     157,871  
Other income (expense)          
Interest expense before merger-related fair value ($43,775 ) ($48,547 ) ($40,303 ) ($15,543 ) ($24,760 )
Merger-related fair value debt adjustment   (9,269 )   (11,844 )            
Interest expense   (53,044 )   (60,391 )   (40,303 )   (15,543 )   (24,760 )
Gain on sales of real estate properties   143,908     143,908     8,496     8,496      
Loss on extinguishment of debt   (1,091 )   (1,091 )   (3,615 )       (3,615 )
Equity loss from unconsolidated joint ventures   (124 )   (124 )   94     (307 )   401  
Interest and other income (expense), net   (172 )   (172 )   9     (125 )   134  
    89,477     82,130     (35,319 )   (7,479 )   (27,840 )
Net income $28,616   $21,533   $20,552   $6,130   $14,422  
Net income attributable to non-controlling interests   (312 )   (316 )   (254 )       (254 )
Net income attributable to common stockholders $28,304   $21,217   $20,298   $6,130   $14,168  
           
           
MERGER-RELATED FAIR VALUE ADJUSTMENTS          
    PROFORMA FULLQUARTER   PER SHARE      
Merger-related fair value debt adjustment     (11,844 ) ($0.031 )    
           
G&A SYNERGIES          
    QUARTERLYAMOUNT   PER SHARE      
Q2 2022 combined   $24,783        
Legacy HTA normalizing adjustments     (1,700 )      
Q2 2022 normalized combined     23,083        
Q3 2022 realized synergies     (4,127 ) ($0.011 )    
Q3 2022 proforma full quarter     18,956        
Remaining expected synergies     (4,500 ) ($0.012 )    
  1. On July 20, 2022, Legacy HR and Legacy HTA closed the merger of the two companies, in which Legacy HR was the acquirer under GAAP. Accordingly, the historic financial statements of the combined company are those of Legacy HR. Unless otherwise noted, third quarter data is for the combined company, whether on an actual or pro forma basis.
  2. Includes third party and travel costs related to the pursuit of acquisitions and developments.
Reconciliation of FFO, Normalized FFO and FAD 1,2,3
DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA
           
  3Q 2022 2Q 2022
  AS REPORTED   PROFORMA FULLQUARTER   COMBINED   LEGACY HR   LEGACY HTA  
Net income attributable to common stockholders $28,304   $21,217   $20,298   $6,130   $14,168  
(Gain) loss on sales of real estate assets   (143,908 )   (143,908 )   (8,496 )   (8,496 )    
Real estate depreciation and amortization   159,643     188,131     131,778     57,334     74,444  
Noncontrolling income (loss) from partnership units   377     316     254         254  
Unconsolidated JV depreciation and amortization   3,526     3,526     3,295     2,807     488  
FFO $47,942   $69,282   $147,129   $57,775   $89,354  
Acquisition and pursuit costs 4   482     482     1,449     1,352     97  
Merger-related costs   79,402     79,402     12,192     7,085     5,107  
Lease intangible amortization   (2 )   127     815     584     231  
Non-routine legal costs/forfeited earnest money received 5   346     346     1,842     140     1,702  
Debt financing costs   1,091     1,091     4,716         4,716  
Unconsolidated JV normalizing items 6   154     154     83     83      
Normalized FFO $129,415   $150,884   $168,226   $67,019   $101,207  
Non-real estate depreciation and amortization   577     577     1,780     556     1,224  
Non-cash interest amortization 7   8,924     11,499     747     747      
Provision for bad debt, net   457     457     16     16      
Straight-line rent income, net   (7,715 )   (9,908 )   (3,743 )   (1,327 )   (2,416 )
Stock-based compensation   3,666     3,666     5,547     3,356     2,191  
Unconsolidated JV non-cash items 8   (377 )   (377 )   (242 )   (242 )    
Normalized FFO adjusted for non-cash items   134,947     156,798     172,331     70,125     102,206  
2nd generation TI   (10,147 )   (11,763 )   (13,635 )   (5,051 )   (8,584 )
Leasing commissions paid   (8,283 )   (8,739 )   (7,251 )   (3,475 )   (3,776 )
Capital expenditures   (16,067 )   (17,461 )   (11,726 )   (4,557 )   (7,169 )
Total maintenance capex   (34,497 )   (37,963 )   (32,612 )   (13,083 )   (19,529 )
FAD $100,450   $118,835   $139,719   $57,042   $82,677  
Quarterly dividends 9 $103,174   $119,194   $122,862   $47,097   $75,765  
FFO per common share - diluted $0.14   $0.18   $0.38   $0.38   $0.38  
Normalized FFO per common share - diluted $0.39   $0.39   $0.44   $0.45   $0.43  
FFO wtd avg common shares outstanding - diluted 10   332,819     384,615     383,670     150,545     233,125  
  1. On July 20, 2022, Legacy HR and Legacy HTA closed the merger of the two companies, in which Legacy HR was the acquirer under GAAP. Accordingly, the historic financial statements of the combined company are those of Legacy HR. Unless otherwise noted, third quarter data is for the combined company, whether on an actual or pro forma basis.
  2. Funds from operations (“FFO”) and FFO per share are operating performance measures adopted by the National Association of Real Estate Investment Trusts, Inc. (“NAREIT”). NAREIT defines FFO as “net income (computed in accordance with GAAP) excluding depreciation and amortization related to real estate, gains and losses from the sale of certain real estate assets, gains and losses from change in control, and impairment write-downs of certain real assets and investments in entities when the impairment is directly attributable to decreases in the value of depreciable real estate held by the entity.”
  3. FFO, Normalized FFO and Funds Available for Distribution ("FAD") do not represent cash generated from operating activities determined in accordance with accounting principles generally accepted in the United States of America and is not necessarily indicative of cash available to fund cash needs. FFO, Normalized FFO and FAD should not be considered alternatives to net income attributable to common stockholders as indicators of the Company's operating performance or as alternatives to cash flow as measures of liquidity.
  4. Acquisition and pursuit costs include third party and travel costs related to the pursuit of acquisitions and developments.
  5. Non-routine legal costs include expenses related to two separate disputes; one with a contractor on a $60.6 million completed construction project and another with a tenant on a violation of use restrictions. Forfeited earnest money received related to a disposition that did not materialize.
  6. Includes the Company's proportionate share of normalizing items related to unconsolidated joint ventures such as lease intangibles and acquisition and pursuit costs.
  7. Includes the amortization of deferred financing costs, discounts and premiums, and non-cash financing receivable amortization.
  8. Includes the Company's proportionate share of straight-line rent, net and provision for bad debt, net related to unconsolidated joint ventures.
  9. Quarterly dividends for the third quarter represent dividends at the current rate of $0.31 per share multiplied by the weighted average shares outstanding. Actual dividends paid in the third quarter were $72.1 million.
  10. The Company utilizes the treasury stock method which includes the dilutive effect of nonvested share-based awards outstanding of 787,559 for the three months ended September 30, 2022.
Reconciliation of Non-GAAP Measures
DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA - UNAUDITED
 

Management considers funds from operations ("FFO"), FFO per share, normalized FFO, normalized FFO per share, funds available for distribution ("FAD") to be useful non-GAAP measures of the Company's operating performance. A non-GAAP financial measure is generally defined as one that purports to measure historical financial performance, financial position or cash flows, but excludes or includes amounts that would not be so adjusted in the most comparable measure determined in accordance with GAAP. Set forth below are descriptions of the non-GAAP financial measures management considers relevant to the Company's business and useful to investors.

The non-GAAP financial measures presented herein are not necessarily identical to those presented by other real estate companies due to the fact that not all real estate companies use the same definitions. These measures should not be considered as alternatives to net income (determined in accordance with GAAP), as indicators of the Company's financial performance, or as alternatives to cash flow from operating activities (determined in accordance with GAAP) as measures of the Company's liquidity, nor are these measures necessarily indicative of sufficient cash flow to fund all of the Company's needs.

FFO and FFO per share are operating performance measures adopted by the National Association of Real Estate Investment Trusts, Inc. (“NAREIT”). NAREIT defines FFO as “net income (computed in accordance with GAAP) excluding depreciation and amortization related to real estate, gains and losses from the sale of certain real estate assets, gains and losses from change in control, and impairment write-downs of certain real assets and investments in entities when the impairment is directly attributable to decreases in the value of depreciable real estate held by the entity.” The Company defines Normalized FFO as FFO excluding acquisition-related expenses, lease intangible amortization and other normalizing items that are unusual and infrequent in nature. FAD is presented by adding to Normalized FFO non-real estate depreciation and amortization, deferred financing fees amortization, share-based compensation expense and provision for bad debts, net; and subtracting maintenance capital expenditures, including second generation tenant improvements and leasing commissions paid and straight-line rent income, net of expense. The Company's definition of these terms may not be comparable to that of other real estate companies as they may have different methodologies for computing these amounts. FFO, Normalized FFO and FAD do not represent cash generated from operating activities determined in accordance with GAAP and are not necessarily indicative of cash available to fund cash needs. FFO, Normalized FFO and FAD should not be considered an alternative to net income as an indicator of the Company’s operating performance or as an alternative to cash flow as a measure of liquidity. FFO, Normalized FFO and FAD should be reviewed in connection with GAAP financial measures.

Management believes FFO, FFO per share, Normalized FFO, Normalized FFO per share, and FAD provide an understanding of the operating performance of the Company’s properties without giving effect to certain significant non-cash items, including depreciation and amortization expense. Historical cost accounting for real estate assets in accordance with GAAP assumes that the value of real estate assets diminishes predictably over time. However, real estate values instead have historically risen or fallen with market conditions. The Company believes that by excluding the effect of depreciation, amortization, gains or losses from sales of real estate, and other normalizing items that are unusual and infrequent, FFO, FFO per share, Normalized FFO, Normalized FFO per share and FAD can facilitate comparisons of operating performance between periods. The Company reports these measures because they have been observed by management to be the predominant measures used by the REIT industry and by industry analysts to evaluate REITs and because these measures are consistently reported, discussed, and compared by research analysts in their notes and publications about REITs.

Cash NOI and Same Store Cash NOI are key performance indicators. Management considers these to be supplemental measures that allow investors, analysts and Company management to measure unlevered property-level operating results. The Company defines Cash NOI as rental income and less property operating expenses. Cash NOI excludes non-cash items such as above and below market lease intangibles, straight-line rent, lease inducements, lease termination fees, tenant improvement amortization and leasing commission amortization. Cash NOI is historical and not necessarily indicative of future results.

Same Store Cash NOI compares Cash NOI for stabilized properties. Stabilized properties are properties that have been included in operations for the duration of the year-over-year comparison period presented. Accordingly, stabilized properties exclude properties that were recently acquired or disposed of, properties classified as held for sale, properties undergoing redevelopment, and newly redeveloped or developed properties.

The Company utilizes the redevelopment classification for properties where management has approved a change in strategic direction for such properties through the application of additional resources including an amount of capital expenditures significantly above routine maintenance and capital improvement expenditures. These properties are described in additional detail in Footnote 6 to the Condensed Consolidated Financial Statements.

Any recently acquired property will be included in the same store pool once the Company has owned the property for eight full quarters. Newly developed or redeveloped properties will be included in the same store pool eight full quarters after substantial completion.

Ron HubbardVice President, Investor RelationsP: 615.269.8290

Healthcare Realty (NYSE:HR)
Historical Stock Chart
Von Jan 2023 bis Feb 2023 Click Here for more Healthcare Realty Charts.
Healthcare Realty (NYSE:HR)
Historical Stock Chart
Von Feb 2022 bis Feb 2023 Click Here for more Healthcare Realty Charts.